Short- and Mid-Term Outcomes of Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation in Octogenarians

Yojiro Machii1, Takashi Kakuta1, Naonori Kawamoto1

  • 1Department of Cardiac Surgery, National Cerebral and Cardiovascular Research Center Osaka Japan.

Circulation Reports
|June 11, 2026
PubMed
Abstract

Insights

Robotic mitral valve repair (r-MVr) is safe and feasible for octogenarians. This minimally invasive approach shows acceptable short- and mid-term outcomes in patients aged 80 and older.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Geriatric Cardiology

Background:

  • Robotic mitral valve repair (r-MVr) offers potential benefits but its safety in octogenarians (≥80 years) is not well-established.
  • Degenerative mitral regurgitation is a common condition requiring intervention in the elderly population.

Purpose of the Study:

  • To evaluate the safety and feasibility of r-MVr in patients aged 80 years and older.
  • To compare short- and mid-term outcomes of r-MVr versus conventional MVr (c-MVr) in this specific patient group.

Main Methods:

  • Single-center retrospective cohort study of 53 patients (≥80 years) with degenerative mitral regurgitation.
  • Comparison between 31 patients undergoing r-MVr (da Vinci Xi system) and 22 patients undergoing c-MVr.
  • Primary outcomes included 30-day mortality, major complications, and length of stay; secondary outcomes included echocardiographic findings and mid-term survival.

Main Results:

  • One 30-day death occurred in the r-MVr group (3.2%) due to intestinal ischemia; no deaths occurred in the c-MVr group.
  • r-MVr was associated with a shorter postoperative hospital stay (12 vs. 13 days; P=0.04).
  • Lower transmitral pressure gradient post-procedure in r-MVr group (2.1 vs. 3.0 mmHg; P=0.02) and no significant differences in 5-year survival or freedom from recurrent mitral regurgitation.

Conclusions:

  • Robotic mitral valve repair (r-MVr) is a safe and feasible minimally invasive option for octogenarians.
  • The procedure demonstrates acceptable short- and mid-term outcomes in patients aged 80 and older.
  • r-MVr may be a viable alternative to conventional repair in this elderly demographic.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...